The project provides for building a facility for production of vaccines and pharmaceuticals in the municipal area of Pereslavl'-Zalessky, 150 kilometers (85 miles) northeast of Moscow.
The project aims at production of new generation vaccines, including a polyvalent human flu vaccine, and pharmaceuticals for detoxification in oncological therapy and for treatment of amyotrophic lateral sclerosis (ALS/Lou Gehrig's disease).
NTpharma's technology allows to reduce by half the time required for culturing and production of the vaccine. This advantage is vital when dealing with vaccines for pandemic flu strains spreading rapidly all over the world.
All vaccines and pharmaceuticals are protected intellectual property of NTpharma LLC.
Nanovaccines and biopharmaceuticals in pseudoadenoviral nanoparticles and self-assembling nanostruct
RUSNANO to invest in building a plant for manufacturing nano-vaccines and therapeutic biopharmaceuti
project for the production of vaccines and biopharmaceuticals has been approved by the Supervisory Council of RUSNANO. Project plans include development of two vaccines for human flu and bird flu and three biopharmaceuticals for treatment of cancer-related toxicity, boosting of the immune system and increasing the efficiency of antibacterial and antiviral drugs, and treatment of lower extremity ischemia and motor neuron disease. Show more...